M Gerold

783 total citations
34 papers, 638 citations indexed

About

M Gerold is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M Gerold has authored 34 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M Gerold's work include Eicosanoids and Hypertension Pharmacology (8 papers), Receptor Mechanisms and Signaling (7 papers) and Nitric Oxide and Endothelin Effects (5 papers). M Gerold is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (8 papers), Receptor Mechanisms and Signaling (7 papers) and Nitric Oxide and Endothelin Effects (5 papers). M Gerold collaborates with scholars based in Switzerland, United States and Canada. M Gerold's co-authors include H. Thoenen, Kazuo Nakamura, Guenther Haeusler, G. Haeusler, Keiji Nakamura, Mark Holck, Franz Hefti, W. Haefely, R. Scherschlicht and P. Polc and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Cellular and Molecular Life Sciences.

In The Last Decade

M Gerold

33 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Gerold Switzerland	12	208	200	171	158	72	34	638
S Fénard France	11	248 1.2×	313 1.6×	118 0.7×	173 1.1×	60 0.8×	20	624
J.R. Boissier France	10	326 1.6×	297 1.5×	171 1.0×	117 0.7×	56 0.8×	16	788
C.A. Hamilton United Kingdom	14	202 1.0×	313 1.6×	212 1.2×	157 1.0×	71 1.0×	36	737
J Velly France	17	207 1.0×	355 1.8×	129 0.8×	184 1.2×	45 0.6×	43	758
Marie L. Steenberg United States	17	199 1.0×	247 1.2×	174 1.0×	216 1.4×	63 0.9×	33	717
Walter Osswald Portugal	17	291 1.4×	360 1.8×	182 1.1×	263 1.7×	95 1.3×	83	920
Jai D. Kohli United States	13	251 1.2×	276 1.4×	104 0.6×	127 0.8×	42 0.6×	32	641
F Lefèvre-Borg France	18	300 1.4×	398 2.0×	170 1.0×	193 1.2×	62 0.9×	28	821
H Schmitt France	11	237 1.1×	235 1.2×	113 0.7×	200 1.3×	48 0.7×	21	567
D D Smyth Canada	17	186 0.9×	366 1.8×	142 0.8×	101 0.6×	69 1.0×	37	665

Countries citing papers authored by M Gerold

Since Specialization

Citations

This map shows the geographic impact of M Gerold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Gerold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Gerold more than expected).

Fields of papers citing papers by M Gerold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Gerold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Gerold. The network helps show where M Gerold may publish in the future.

Co-authorship network of co-authors of M Gerold

This figure shows the co-authorship network connecting the top 25 collaborators of M Gerold. A scholar is included among the top collaborators of M Gerold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Gerold. M Gerold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gerold, M & Ruth Adler. (1995). Hodgkin's disease as an indicator of AIDS. Medical Hypotheses. 45(1). 76–82. 5 indexed citations

Gerold, M & Ruth Adler. (1992). Manifestations of pediatric AIDS: Proposed mechanisms of transmission. Medical Hypotheses. 37(4). 205–212. 1 indexed citations

Bossé, Roger, et al.. (1990). An Angiotensin with Prolonged Action and Blood Pressure-Lowering Properties. Journal of Cardiovascular Pharmacology. 16(Supplement 4). S50–S55. 10 indexed citations

Gerold, M, et al.. (1987). Cardiovascular effects of three calcium entry blockers in conscious dogs.. PubMed. 37(9). 1020–5. 2 indexed citations

Holck, Mark, Walter Fischli, Franz Hefti, & M Gerold. (1986). Cardiovascular Effects of the New Angiotensin-Converting-Enzyme Inhibitor, Cilazapril, in Anesthetized and Conscious Dogs. Journal of Cardiovascular Pharmacology. 8(1). 99–108. 25 indexed citations

Holck, Mark & M Gerold. (1985). Calcium entry blockers inhibit vasoconstrictor responses to sympathetic nerve stimulation mediated by ?1-adrenoceptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 330(1). 22–32. 10 indexed citations

Gerold, M, et al.. (1984). The effects of bufuralol, a beta-adrenoceptor antagonist with predominant beta 2-adrenoceptor agonistic activity, in the cat and the dog.. PubMed. 6(1). 165–75. 5 indexed citations

Haeusler, G., et al.. (1982). Overview on the Pharmacological and Toxicological Characterization of the Calcium Antagonist Tiapamil. Cardiology. 69(1). 31–57. 10 indexed citations

Gerold, M & Guenther Haeusler. (1982). The influence of SK & F 64139, a phenylethanolamine-N-methyltransferase inhibitor, on centrally mediated cardiovascular effects of ?-methyldopa and clonidine. Naunyn-Schmiedeberg s Archives of Pharmacology. 321(4). 276–281. 2 indexed citations

10.

Gerold, M, et al.. (1982). Cardiovascular Effects of Tiapamil (Ro 11–1781), a New Calcium-Entry Blocker. Journal of Cardiovascular Pharmacology. 4(3). 419–429. 13 indexed citations

11.

Gerold, M, et al.. (1981). Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713.. Journal of Pharmacology and Experimental Therapeutics. 216(3). 624–633. 6 indexed citations

12.

Pieri, L., R. Schaffner, R. Scherschlicht, et al.. (1981). Pharmacology of midazolam.. PubMed. 31(12a). 2180–201. 127 indexed citations

13.

Gerold, M, et al.. (1978). The cardiovascular effects of the antihypertensive drug debrisoquin: a contribution to the pharmacology of chronic treatment. I. One-week administration to dogs.. Journal of Pharmacology and Experimental Therapeutics. 206(1). 123–131. 2 indexed citations

14.

Borgulya, J., M Gerold, F Schneider, & Karl Bernauer. (1977). Chemische und pharmakologische Studien über Derivate des Benzo[de]chinolins. II. 10.Mitteilung über natürliche und synthetische Isochinolinderivate. Helvetica Chimica Acta. 60(2). 598–617.

15.

Schneider, F, M Gerold, & Karl Bernauer. (1973). Chemische und pharmakologische Studien über Derivate des Benzo[de]chinolins (I). 8. Mitteilung über natürliche und synthetische Isochinolinderivate. Helvetica Chimica Acta. 56(2). 759–773. 5 indexed citations

16.

Gerold, M, et al.. (1972). Implantable Blood Pressure Telemetry System. IEEE Transactions on Biomedical Engineering. BME-19(5). 334–341. 8 indexed citations

17.

Haeusler, G., M Gerold, & H. Thoenen. (1972). Cardiovascular effects of 6-hydroxydopamine injected into a lateral brain ventricle of the rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 274(3). 211–228. 42 indexed citations

18.

Nakamura, Kazuo, M Gerold, & H. Thoenen. (1970). EXPERIMENTAL HYPERTENSION OF THE RAT: RECIPROCAL CHANGES OF NOREPINEPHRINE TURNOVER IN HEART AND BRAIN-STEM. The Japanese Journal of Pharmacology. 20(4). 605–607. 26 indexed citations

19.

Gerold, M. (1968). [Effect of tyramine and cheese on the blood pressure and their modification by DL-serine-N2-isopropylhydrazide (Ro 4-1038) on awake intact dogs].. PubMed. 18(9). 1198–200. 1 indexed citations

20.

Thoenen, H., M Gerold, W. Haefely, & A. Huerlimann. (1968). Norepinephrine depleting and antihypertensive effect of 4-methoxy-3,5-dihydroxyphenylalanine. Cellular and Molecular Life Sciences. 24(2). 158–159. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact